Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.8B | 6.3B | 7.3B | 6.5B |
Cost of revenue | 4.0B | 3.7B | 3.3B | 3.0B |
Gross profit | 3.7B | 2.7B | 4.0B | 3.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 0 | — | -21M |
Operating income | 2.0B | 1.1B | 2.4B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 714M | 693M | 692M | 694M |
Other income expense | 254M | 180M | 236M | 233M |
Pretax income | 1.6B | 545M | 1.9B | 1.5B |
Tax provision | 280M | 79M | 377M | 290M |
Net income | 1.3B | 466M | 1.5B | 1.2B |
Basic EPS | 1.2 | 0.5 | 1.4 | 1.1 |
Diluted EPS | 1.2 | 0.5 | 1.4 | 1.1 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 3.6B | 2.5B | 3.9B | 3.4B |
Net income from continuing op. | 1.3B | 466M | 1.5B | 1.2B |
Minority interests | 64M | 68M | 0 | 15M |
Preferred stock dividends | — | — | — | — |